Consolidated Statements Of Shareholders' Equity - USD ($) $ in Thousands |
Total |
Convertible Preferred Stock |
Common Stock and Additional Paid-in Capital |
Treasury Stock |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
| Balance at Dec. 31, 2013 |
$ 8,481
|
|
$ 148,904
|
$ (16,399)
|
$ (274)
|
$ (123,750)
|
| Balance, shares at Dec. 31, 2013 |
|
|
37,336,000
|
|
|
|
| Treasury Stock Shares at Dec. 31, 2013 |
(1,964,000)
|
|
|
|
|
|
| Exercise of stock options, net, shares |
|
|
153,000
|
|
|
|
| Exercise of stock options, net |
$ 310
|
|
$ 310
|
|
|
|
| Stock-based compensation |
$ 1,233
|
|
1,233
|
|
|
|
| Retirement of treasury stock |
|
|
$ (16,399)
|
$ 16,399
|
|
|
| Retirement of treasury stock, shares |
1,964,000
|
|
(1,964,000)
|
|
|
|
| Other compensation |
$ 123
|
|
$ 123
|
|
|
|
| Issuance of stock, net, shares |
|
|
22,359,000
|
|
|
|
| Issuance of stock, net |
51,118
|
|
$ 51,118
|
|
|
|
| Exercise of warrants, shares |
|
|
39,000
|
|
|
|
| Stock dividends |
|
|
192,000
|
|
|
|
| Net loss |
(18,926)
|
|
|
|
|
(18,926)
|
| Foreign currency translation adjustments |
(283)
|
|
|
|
(283)
|
|
| Balance at Dec. 31, 2014 |
42,056
|
|
$ 185,289
|
|
(557)
|
(142,676)
|
| Balance, shares at Dec. 31, 2014 |
|
|
58,115,000
|
|
|
|
| Exercise of stock options, net, shares |
|
|
113,000
|
|
|
|
| Exercise of stock options, net |
44
|
|
$ 44
|
|
|
|
| Stock-based compensation |
3,350
|
|
3,350
|
|
|
|
| Cost of issuance |
(3)
|
|
(3)
|
|
|
|
| Net loss |
(20,278)
|
|
|
|
|
(20,278)
|
| Foreign currency translation adjustments |
(244)
|
|
|
|
(244)
|
|
| Balance at Dec. 31, 2015 |
$ 24,925
|
|
$ 188,680
|
|
(801)
|
(162,954)
|
| Balance, shares at Dec. 31, 2015 |
58,228,000
|
|
58,228,000
|
|
|
|
| Exercise of stock options, net |
$ 1
|
|
$ 1
|
|
|
|
| Stock-based compensation |
3,065
|
|
$ 3,065
|
|
|
|
| Issuance of stock from RSUs, net |
|
|
489,000
|
|
|
|
| Issuance of Series C participating convertible preferred stock and warrants, net of issuance cost of $479 |
9,520
|
$ 8,428
|
$ 1,092
|
|
|
|
| Issuance of Series C participating convertible preferred stock and warrants, shares |
|
88,000
|
|
|
|
|
| Beneficial conversion feature of Series C participating convertible preferred stock |
|
$ (1,092)
|
1,092
|
|
|
|
| Deemed dividend related to beneficial conversion feature of Series C participating convertible preferred stock |
(2,184)
|
2,184
|
(2,184)
|
|
|
|
| Issuance of common stock upon conversion of Series C participating convertible preferred stock |
|
$ (9,520)
|
$ 9,520
|
|
|
|
| Issuance of common stock upon conversion of Series C participating convertible preferred stock, shares |
|
(88,000)
|
8,849,000
|
|
|
|
| Net loss |
(15,371)
|
|
|
|
|
(15,371)
|
| Foreign currency translation adjustments |
(75)
|
|
|
|
(75)
|
|
| Balance at Dec. 31, 2016 |
$ 22,065
|
|
$ 201,266
|
|
$ (876)
|
$ (178,325)
|
| Balance, shares at Dec. 31, 2016 |
67,565,951
|
|
67,566,000
|
|
|
|